BRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch Program

Reuters

Nov 26, 2024

BRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch Program

Nov 26 (Reuters) - Embecta Corp EMBC.O:

. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS; PROVIDES INITIAL FISCAL YEAR 2025 FINANCIAL GUIDANCE; DISCONTINUES INSULIN PATCH PUMP PROGRAM; AND ANNOUNCES RESTRUCTURING TO STREAMLINE OPERATIONS AND REDUCE COSTS
EMBECTA - WILL INCUR PRE-TAX, CASH CHARGES FOR PLANNED WORKFORCE REDUCTIONS & OTHER ASSOCIATED COSTS FROM DISCONTINUATION OF PATCH PUMP PROGRAM
: QTRLY EPS $0.25
Q4 EARNINGS PER SHARE VIEW $0.36 -- LSEG IBES DATA
EMBECTA - EXPECTS DISCONTINUATION OF PATCH PUMP PROGRAM & ORGANIZATIONAL TO GENERATE ANNUALIZED PRE-TAX COST SAVINGS BETWEEN $60 MILLION & $65 MILLION
: QTRLY ADJUSTED EPS $0.45
: OUTLOOK FY25 REVENUE $1,093 MILLION - $1,110 MILLION
FY2024 EARNINGS PER SHARE VIEW $2.39, REVENUE VIEW $1.11 BILLION -- LSEG IBES DATA
OUTLOOK FY25 ADJUSTED EPS $2.70 - $2.90
FY2025 EARNINGS PER SHARE VIEW $2.27 -- LSEG IBES DATA

Source text: ID:nGNX2VqhBq

Further company coverage: EMBC.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2486075067"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2486075067\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2486075067?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-26 19:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2486075067","market":"us","top_or_hot":-1,"title":"BRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch Program","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch Program</title></head><body><p><span>Nov 26 (Reuters)</span><span> - </span>Embecta Corp <span>EMBC.O</span>:</p><ul><li><p>. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS; PROVIDES INITIAL FISCAL YEAR 2025 FINANCIAL GUIDANCE; DISCONTINUES INSULIN PATCH PUMP PROGRAM; AND ANNOUNCES RESTRUCTURING TO STREAMLINE OPERATIONS AND REDUCE COSTS</p></li><li><p>EMBECTA - WILL INCUR PRE-TAX, CASH CHARGES FOR PLANNED WORKFORCE REDUCTIONS &amp; OTHER ASSOCIATED COSTS FROM DISCONTINUATION OF PATCH PUMP PROGRAM</p></li><li><p>: QTRLY EPS $0.25</p></li><li><p>Q4 EARNINGS PER SHARE VIEW $0.36 -- LSEG IBES DATA</p></li><li><p>EMBECTA - EXPECTS DISCONTINUATION OF PATCH PUMP PROGRAM &amp; ORGANIZATIONAL TO GENERATE ANNUALIZED PRE-TAX COST SAVINGS BETWEEN $60 MILLION &amp; $65 MILLION</p></li><li><p>: QTRLY ADJUSTED EPS $0.45</p></li><li><p>: OUTLOOK FY25 REVENUE $1,093 MILLION - $1,110 MILLION</p></li><li><p>FY2024 EARNINGS PER SHARE VIEW $2.39, REVENUE VIEW $1.11 BILLION -- LSEG IBES DATA</p></li><li><p>OUTLOOK FY25 ADJUSTED EPS $2.70 - $2.90</p></li><li><p>FY2025 EARNINGS PER SHARE VIEW $2.27 -- LSEG IBES DATA</p></li></ul><p>Source text: <span>ID:nGNX2VqhBq</span></p><p>Further company coverage: <span>EMBC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch Program</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch Program\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-11-26 19:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch Program</title></head><body><p><span>Nov 26 (Reuters)</span><span> - </span>Embecta Corp <span>EMBC.O</span>:</p><ul><li><p>. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS; PROVIDES INITIAL FISCAL YEAR 2025 FINANCIAL GUIDANCE; DISCONTINUES INSULIN PATCH PUMP PROGRAM; AND ANNOUNCES RESTRUCTURING TO STREAMLINE OPERATIONS AND REDUCE COSTS</p></li><li><p>EMBECTA - WILL INCUR PRE-TAX, CASH CHARGES FOR PLANNED WORKFORCE REDUCTIONS &amp; OTHER ASSOCIATED COSTS FROM DISCONTINUATION OF PATCH PUMP PROGRAM</p></li><li><p>: QTRLY EPS $0.25</p></li><li><p>Q4 EARNINGS PER SHARE VIEW $0.36 -- LSEG IBES DATA</p></li><li><p>EMBECTA - EXPECTS DISCONTINUATION OF PATCH PUMP PROGRAM &amp; ORGANIZATIONAL TO GENERATE ANNUALIZED PRE-TAX COST SAVINGS BETWEEN $60 MILLION &amp; $65 MILLION</p></li><li><p>: QTRLY ADJUSTED EPS $0.45</p></li><li><p>: OUTLOOK FY25 REVENUE $1,093 MILLION - $1,110 MILLION</p></li><li><p>FY2024 EARNINGS PER SHARE VIEW $2.39, REVENUE VIEW $1.11 BILLION -- LSEG IBES DATA</p></li><li><p>OUTLOOK FY25 ADJUSTED EPS $2.70 - $2.90</p></li><li><p>FY2025 EARNINGS PER SHARE VIEW $2.27 -- LSEG IBES DATA</p></li></ul><p>Source text: <span>ID:nGNX2VqhBq</span></p><p>Further company coverage: <span>EMBC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EMBC","symbol_name":"Embecta Corp.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA3J499C:1","article_id":"2486075067","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486075067","pubTimestamp":1732621366,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch ProgramNov 26 (Reuters) - Embecta Corp EMBC.O:. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL R","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EMBC":"Embecta Corp.","BK4198":"医疗保健用品"},"translate_title":"简介-Embecta报告第四季度和2024财年业绩，提供2025财年指导，结束胰岛素贴片计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMBC":0.9},"content_text":"BRIEF-Embecta Reports Q4 and FY 2024 Results, Provides FY 2025 Guidance, Ends Insulin Patch ProgramNov 26 (Reuters) - Embecta Corp EMBC.O:. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS; PROVIDES INITIAL FISCAL YEAR 2025 FINANCIAL GUIDANCE; DISCONTINUES INSULIN PATCH PUMP PROGRAM; AND ANNOUNCES RESTRUCTURING TO STREAMLINE OPERATIONS AND REDUCE COSTSEMBECTA - WILL INCUR PRE-TAX, CASH CHARGES FOR PLANNED WORKFORCE REDUCTIONS & OTHER ASSOCIATED COSTS FROM DISCONTINUATION OF PATCH PUMP PROGRAM: QTRLY EPS $0.25Q4 EARNINGS PER SHARE VIEW $0.36 -- LSEG IBES DATAEMBECTA - EXPECTS DISCONTINUATION OF PATCH PUMP PROGRAM & ORGANIZATIONAL TO GENERATE ANNUALIZED PRE-TAX COST SAVINGS BETWEEN $60 MILLION & $65 MILLION: QTRLY ADJUSTED EPS $0.45: OUTLOOK FY25 REVENUE $1,093 MILLION - $1,110 MILLIONFY2024 EARNINGS PER SHARE VIEW $2.39, REVENUE VIEW $1.11 BILLION -- LSEG IBES DATAOUTLOOK FY25 ADJUSTED EPS $2.70 - $2.90FY2025 EARNINGS PER SHARE VIEW $2.27 -- LSEG IBES DATASource text: ID:nGNX2VqhBqFurther company coverage: EMBC.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}